ERYNN BROWN: Open Payments
NPI 1245854702 · MOUNT CLEMENS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 37 payments from 13 companies in 2025. Trend: 2023 $905 · 2024 $713 · 2025 $808
Food & beverage: $709Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $234 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $95 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Organon LLC | 3 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Hologic Sales and Service, LLC | 2 | $55 |
| Sage Therapeutics, LLC | 2 | $51 |
| Exeltis, USA Inc. | 3 | $50 |
| MILLICENT US INC | 2 | $40 |
| Dexcom, Inc. | 1 | $27 |
Products named: Veozah, INJECTAFER, NEXPLANON, MYFEMBREE, ZURZUVAE, SLYND, FEMLYV, CoolSeal Generator.
Industry payments across MI — which companies pay providers there.
